Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Hofer

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Frontiers in Psychiatry|June 2, 2020
Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer's Dementia: A Clinical Case ReportMichaela Defrancesco, Alex Hofer
Journal of Clinical Psychopharmacology|April 11, 2014
Pulmonary embolism and aspiration pneumonia after reexposure to clozapine: pulmonary adverse effects of clozapineStefan Schmidinger, Alex Hofer
Zeitschrift Fur Gerontologie Und Geriatrie|August 16, 2018
[Diseases of the schizophrenia spectrum disorder in old age : Diagnostic and therapeutic challenges]Christian Jagsch, Alex Hofer
Frontiers in Neuroimaging|August 9, 2023
Resting-state functional MRI in treatment-resistant schizophreniaNoora Tuovinen, Alex Hofer
Journal of Clinical Psychopharmacology|June 16, 2015
Treating Schizophrenia With 2 Long-Acting Injectable Antipsychotic Drugs: A Case ReportFabienne Wartelsteiner, Alex Hofer
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|June 30, 2023
[Safety aspects during treatment with clozapine. : Monitoring and rechallenge - a narrative review]Stefan J Berger, Alex Hofer
Current Opinion in Psychiatry|February 18, 2017
Ability-based emotional intelligence in schizophreniaBeatrice Frajo-Apor, Alex Hofer
Current Opinion in Psychiatry|March 12, 2014
Social cognition in serious mental illnessChristine M Hoertnagl, Alex Hofer
Acta Psychiatrica Scandinavica|February 10, 2006
Attitudes towards medication in patients with schizophreniaAlex Hofer, W Wolfgang Fleischhacker
Current Opinion in Psychiatry|February 6, 2019
Antipsychotic-induced tardive dyskinesia: update on epidemiology and managementChristian G Widschwendter, Alex Hofer
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Frontiers in Psychiatry|June 2, 2020
Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer's Dementia: A Clinical Case ReportMichaela Defrancesco, Alex Hofer
Journal of Clinical Psychopharmacology|April 11, 2014
Pulmonary embolism and aspiration pneumonia after reexposure to clozapine: pulmonary adverse effects of clozapineStefan Schmidinger, Alex Hofer
Zeitschrift Fur Gerontologie Und Geriatrie|August 16, 2018
[Diseases of the schizophrenia spectrum disorder in old age : Diagnostic and therapeutic challenges]Christian Jagsch, Alex Hofer
Frontiers in Neuroimaging|August 9, 2023
Resting-state functional MRI in treatment-resistant schizophreniaNoora Tuovinen, Alex Hofer
Journal of Clinical Psychopharmacology|June 16, 2015
Treating Schizophrenia With 2 Long-Acting Injectable Antipsychotic Drugs: A Case ReportFabienne Wartelsteiner, Alex Hofer
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|June 30, 2023
[Safety aspects during treatment with clozapine. : Monitoring and rechallenge - a narrative review]Stefan J Berger, Alex Hofer
Current Opinion in Psychiatry|February 18, 2017
Ability-based emotional intelligence in schizophreniaBeatrice Frajo-Apor, Alex Hofer
Current Opinion in Psychiatry|March 12, 2014
Social cognition in serious mental illnessChristine M Hoertnagl, Alex Hofer
Acta Psychiatrica Scandinavica|February 10, 2006
Attitudes towards medication in patients with schizophreniaAlex Hofer, W Wolfgang Fleischhacker
Current Opinion in Psychiatry|February 6, 2019
Antipsychotic-induced tardive dyskinesia: update on epidemiology and managementChristian G Widschwendter, Alex Hofer
Pageof 14